切换至 "中华医学电子期刊资源库"

中华脑血管病杂志(电子版) ›› 2025, Vol. 19 ›› Issue (06) : 550 -554. doi: 10.3877/cma.j.issn.1673-9248.2025.06.015

综述

心源性卒中危险因素的研究进展
卢剑峰, 王亚云, 王佳宁, 苗丹()   
  1. 266000 山东 青岛,青岛市中医医院 青岛大学附属青岛市海慈医院神经内科
  • 收稿日期:2025-07-10 出版日期:2025-12-01
  • 通信作者: 苗丹

Research progress on risk factors for cardiogenic stroke

Jianfeng Lu, Yayun Wang, Jianing Wang, Dan Miao()   

  1. Department of Neurology, Qingdao Traditional Chinese Medicine Hospital, Qingdao Hiser Hospital Affiliated of Qingdao University, Qingdao 266000, China
  • Received:2025-07-10 Published:2025-12-01
  • Corresponding author: Dan Miao
引用本文:

卢剑峰, 王亚云, 王佳宁, 苗丹. 心源性卒中危险因素的研究进展[J/OL]. 中华脑血管病杂志(电子版), 2025, 19(06): 550-554.

Jianfeng Lu, Yayun Wang, Jianing Wang, Dan Miao. Research progress on risk factors for cardiogenic stroke[J/OL]. Chinese Journal of Cerebrovascular Diseases(Electronic Edition), 2025, 19(06): 550-554.

心源性卒中亦称心源性栓塞性卒中(CES),占全部缺血性卒中(IS)的20%~30%。相较于其他原因所致IS,CES的病情更严重、预后更差、复发率更高,故对其进行有效防控,特别是对其危险因素的识别和干预,成为目前亟需解决的关键问题之一。本文综述了近年来CES危险因素的研究进展。

Cardiogenic stroke, also defined as cardioembolic stroke (CES), accounts for 20%-30% of all ischemic stroke. Compared to ischemic stroke caused by other causes, CES has more severe clinical symptoms, poorer prognosis, and higher recurrence rate. Therefore, effective prevention and control of CES, especially the identification and intervention of its risk factors, has become a key clinical priority. This review summarizes recent advances in the understanding of risk factors for CES.

1
袁国宾, 刘广志. 缺血性卒中的诊治现状 [J]. 实用心脑肺血管病杂志, 2024, 32(4): 1-7.
2
Kanjee Z, Dearborn-Tomazos JL, Kumar S, et al. How would you prevent subsequent strokes in this patient? Grand rounds discussion from Beth Israel Deaconess Medical Center [J]. Ann Intern Med, 2024, 177: 238-245.
3
中华医学会老年医学分会老年神经病学组, 心源性卒中诊断中国专家共识撰写组. 心源性卒中诊断中国专家共识(2020) [J]. 中华老年医学杂志, 2020, 39(12): 1369-1378.
4
Kamel H, Healey JS. Cardioembolic stroke [J]. Circ Res, 2017, 120(3): 514-526.
5
Bjerkreim AT, Khanevski AN, Thomassen L, et al. Five-year readmission and mortality differ by ischemic stroke subtype [J]. Neurol Sci, 2019, 403: 31-37.
6
Diener HC, Easton JD, Hart RG, et al. Review and update of the concept of embolic stroke of undetermined source [J]. Nat Rev Neurol, 2022, 18: 455-465.
7
卢蕾, 张宏博, 田亚楠, 等.心源性脑卒中病情发展评估及影响因素 [J]. 实用医学杂志, 2019, 35(7): 1096-1100.
8
张咪咪, 李妮妮. 心源性脑卒中危险因素分析及预防对策探讨 [J]. 贵州医药, 2020, 44(11): 1754-1755.
9
石玉芝, 王春雪, 王献伟, 等. 卒中性别差异的研究进展 [J]. 中国卒中杂志, 2010, 5(3): 217-222.
10
李卫征, 刘鸣, 吴波, 等. 不同性别脑卒中危险因素类型及预后的比较研究 [J]. 中国实用内科杂志, 2009, 29(5): 444-446.
11
Griñán K, Arboix A, Massons J, et al. Cardioembolic stroke: risk factors, clinical features, and early outcome in 956 consecutive patients [J]. Rev Invest Clin, 2020, 73(1): 23-30.
12
Chung JW, Bang OY, Ahn K, et al. Air pollution is associated with ischemic stroke via cardiogenic embolism [J]. Stroke, 2017, 48(1): 17-23.
13
Escudero-Martínez I, Morales-Caba L, Segura T. Atrial fibrillation and stroke: a review and new insights [J]. Trends Cardiovasc Med, 2023, 33(1): 23-29.
14
Kotalczyk A, Mazurek M, Kalarus Z, et al. Stroke prevention strategies in high-risk patients with atrial fibrillation [J]. Nat Rev Cardiol, 2021, 18: 276-290.
15
Zhang C, Kasner SE. Paroxysmal atrial fibrillation in cryptogenic stroke: an overlooked explanation? [J]. Curr Atheroscler Rep, 2015, 17(12): 66.
16
Arauz A, Arteaga C, Zapata-Gómez C, et al. Embolic stroke of undetermined source: beyond atrial fibrillation [J]. Neurologia (Engl Ed), 2022, 37(5): 362-370.
17
Schumacher K, Kornej J, Shantsila E, et al. Heart failure and stroke [J]. Curr Heart Fail Rep, 2018, 15(5): 287-296.
18
Fan ZX, Wang CB, Fang LB, et al. Risk factors and a Bayesian network model to predict ischemic stroke in patients with dilated cardiomyopathy [J]. Front Neurosci, 2022, 16: 1043922.
19
Lu JF, Fan ZX, Li Y, et al. Risk factors, clinical features, and outcomes of patients with hypertrophic cardiomyopathy complicated by ischemic stroke: a single-center retrospective study [J]. Front Cardiovasc Med, 2022, 9: 1054199.
20
Kato Y, Takahashi S. Atrial cardiopathy and cryptogenic stroke [J]. Front Neurol, 2022, 13: 839398.
21
He D, Shi Q, Xu G, et al. Clinical and infarction patterns of PFO-related cryptogenic strokes and a prediction model [J]. Ann Clin Transl Neurol, 2018, 24;5(11): 1323-1337.
22
Sposato LA, Albin CSW, Elkind MSV, et al. Patent foramen ovale management for secondary stroke prevention: state-of-the-art appraisal of current evidence [J]. Stroke, 2024, 55(1): 236-247.
23
Bal D, Ahmed Shaikh AI, Rayani M, et al. Transcranial Doppler screening for patent foramen ovale closure in cryptogenic strokes in young: a single center experience from South India [J]. J Assoc Physicians India, 2022, 70: 11-12.
24
王泽祎, 杨亭亭, 刘广志.卵圆孔未闭相关性卒中的诊治研究进展 [J]. 中国卒中杂志, 2021, 16(9): 960-966.
25
Vasconcelos M, Vasconcelos L, Ribeiro V, et al. Incidence and predictors of stroke in patients with rheumatic heart disease [J]. Heart, 2021, 107(9): 748-754.
26
Butala NM, Makkar R, Secemsky EA, et al. Cerebral embolic protection and outcomes of transcatheter aortic valve replacement: results from the transcatheter valve therapy registry [J]. Circulation, 2021, 143: 2229-2240.
27
Johari MI, Ismail MN, Mohamad F, et al. Rare cause of cardioembolic stroke and central retinal artery occlusion [J]. BMJ Case Rep, 2021, 14(1): e236420.
28
Esteban-Lucía L, De la Fuente Batista S, Kallmeyer Mayor AM, et al. Cardioembolic stroke secondary to an aortic valve fibroelastoma: an increasingly recognized rare cause of stroke [J]. Stroke, 2021, 52(4): e111-e114.
29
Siddiqui A, Rehman S. Cardiac papillary fibroelastoma: a rare cause of cardioembolic stroke [J]. Neurol India, 2022, 70(1): 380-383.
30
徐源振. 急性心肌梗死后室壁瘤患者左心室血栓形成的相关因素分析 [D]. 长春:吉林大学, 2024.
31
罗玉清. 急性ST段抬高型心肌梗死介入治疗后左心室血栓的危险因素分析 [D]. 桂林: 桂林医学院, 2023.
32
谢文, 张纯, 刘金凤, 等. 经胸超声心动图对栓塞性卒中患者心源性栓子的诊断及预后评估 [J]. 心肺血管病杂志, 2023, 42(10): 1056-1061.
33
DiTullio MR, Russo C, Jin Z, et al. Aortic arch plaques and risk of recurrent stroke and death [J]. Circulation, 2009, 119(17): 2376-2382.
34
Yaghi S. Diagnosis and management of cardioembolic stroke [J]. Continuum (Minneap Minn), 2023, 29(2): 462-485.
35
Kojima K, Fukamachi D, Okumura Y. Ischemic stroke patients with non-valvular atrial fibrillation have a risk for aortogenic embolizations [J]. J Atheroscler Thromb, 2021, 28: 786-788.
36
Ueno Y, Tanaka R, Yamashiro K, et al. Impact of BNP on cryptogenic stroke without potential embolic sources on transesophageal echocardiography [J]. J Neurol Sci, 2015, 359(1-2): 287-292.
37
Cao R, Jiang Y, Li L, et al. BNP on admission combined with imaging markers of multimodal CT to predict the risk of cardioembolic stroke [J]. Dis Markers, 2022, 2022: 3327967.
38
Zhang M, Wang Y, Wei J, et al. BNP combined with echocardiographic parameters to predict the risk of cardioembolic stroke [J]. J Clin Neurosci, 2021, 88: 213-218.
39
Rost NS, Biffi A, Cloonan L, et al. Brain natriuretic peptide predicts functional outcome in ischemic stroke [J]. Stroke, 2012, 43(2): 441-445.
40
Llombart V, Antolin-Fontes A, Bustamante A, et al. B-type natriuretic peptides help in cardioembolic stroke diagnosis: pooled data meta-analysis [J]. Stroke, 2015, 46(5): 1187-1195.
41
Arponen O, Muuronen A, Taina M, et al. Acute phase IL-10 plasma concentration associates with the high risk sources of cardiogenic stroke [J]. PLoS One, 2015, 10(4): e0120910.
42
Zou Y, Xu Y, Chen X, et al. Research progress on leucine-rich alpha-2 glycoprotein 1: a review [J]. Front Pharmacol, 2022, 12: 809225.
43
Zhang M, Wang Y, Wang J, et al. Serum LRG1 as a novel biomarker for cardioembolic stroke [J]. Clin Chi Acta, 2021, 519: 83-91.
44
Sethi PK, Rajeswari R, Sethi NK. NT-proBNP in cardioembolic stroke [J]. Neurol India, 2023, 71(4): 866-867.
45
Markus A, Valerie S, Mira K. Promising biomarker candidates for cardioembolic stroke etiology. A brief narrative review and current opinion [J]. Front Neurol, 2021, 12: 624930.
46
Rodriguez-Yanez M, Sobrino T, Blanco M, et al. High serum levels of pro-brain natriuretic peptide (pro BNP) identify cardioembolic origin in undetermined stroke [J]. Dis Markers, 2009, 26: 189-195.
47
Licata G, Tuttolomondo A, Di Raimondo D, et al. Immuno-inflflammatory activation in acute cardio-embolic strokes in comparison with other subtypes of ischaemic stroke [J]. Thromb Haemost, 2009, 101(5): 929-937.
48
Yaghi S, Chang AD, Ricci BA, et al. Early elevated troponin levels after ischemic stroke suggests a cardioembolic source [J]. Stroke, 2018, 49(1): 121-126.
49
Sakai S, Hagii J, Shikanai S, et al. Low creatinine clearance is a risk factor for severe cardioembolic stroke in Japanese female patients [J]. In Vivo, 2023, 37(1): 336-344.
50
Lee EJ, Kim DJ, Kang DW, et al. Targeted metabolomic biomarkers for stroke subtyping [J]. Transl Stroke Res, 2024, 15(2): 422-432.
51
Mukherjee D, Jani ND, Narvid J, et al. The role of circle of Willis anatomy variations in cardio-embolic stroke: a patient-specific simulation based study [J]. Ann Biomed Eng, 2018, 46: 1128-1145.
52
Bae JH, Ryu JC, Ha SH, et al. Association of left vertebral artery hypoplasia with posterior circulation stroke and the functional outcome of patients with atrial fibrillation-related cardioembolic stroke [J]. AJNR Am J Neuroradiol, 2023, 44(1): 65-69.
53
Ha SH, Yang SY, Jeong S, et al. Enlarged left atrium may be associated with laterality of anterior circulation cardioembolic stroke [J]. J Stroke Cerebrovasc Dis, 2023, 32(4): 106999.
54
Panagiotopoulos K, Toumanidis S, Saridakis N, et al. Left atrial and left atrial appendage functional abnormalities in patients with cardioembolic stroke in sinus rhythm and idiopathic atrial fibrillation [J]. J Am Soc Echocardiogr, 1998, 11: 711-719.
55
李雯琳, 张志. 心房颤动患者左心耳形态结构和功能与左心耳血栓及心源性卒中的关系研究进展 [J]. 临床荟萃, 2024, 39(2): 168-171.
[1] 徐留海, 王颉, 田志鹏, 黄晶, 曾勇, 王茂朋, 刘丛钊, 周游. 影响盘状半月板损伤术后疗效的危险因素研究[J/OL]. 中华关节外科杂志(电子版), 2025, 19(05): 528-534.
[2] 陈系东, 王绍闯, 赵何伟, 王硕, 袁维栋. 高龄BCLC B期肝癌患者常规TACE术后急性肝功能恶化的危险因素研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(06): 689-692.
[3] 周金哲, 王贤清, 李自强, 石启蒙, 张久强, 朱俩辰, 黄琦, 葛步军. 低位保肛新术式-结肠肛管套叠式吻合——附2例病例介绍[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(06): 619-623.
[4] 钱龙, 蔡大明, 王行舟, 艾世超, 胡琼源, 孙锋, 宋鹏, 王峰, 王萌, 陆晓峰, 朱欢欢, 沈晓菲, 管文贤. 局部不可切除胃癌转化治疗(联合免疫治疗)后淋巴结转移的相关危险因素分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(06): 624-627.
[5] 肖燕玲, 杜升兰, 杨春梅, 许政文, 王玫. 正中切口在腹腔镜直肠癌根治术预防性回肠造口中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(05): 539-542.
[6] 邓吟咏, 钟洁, 蒋理立, 杨婕. 结直肠肿瘤手术后并发症的预测与预防:基于临床研究的最新进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(05): 579-583.
[7] 周福安, 陈戬. 经皮肾镜碎石取石术后肾功能恶化的围术期影响因素研究进展[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(06): 792-795.
[8] 陈伟东, 赵力, 罗辉, 张汉荣, 李金雨. 经皮肾镜碎石取石术后引起胸腔积液的防治[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(06): 796-799.
[9] 钟秋润, 严丹檎, 范小莉, 陈蓉, 罗坤. 腹股沟疝修补术后发生血清肿危险因素的Meta分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2025, 19(06): 701-706.
[10] 陈晞, 杜海鸥, 张毛为, 刘亚南, 孙宜田, 王倩格, 刘琦, 陈碧. 抗合成酶综合征发生快速进展型间质性肺病的危险因素和预后分析[J/OL]. 中华肺部疾病杂志(电子版), 2025, 18(06): 878-884.
[11] 李艳鸿, 张海颖, 邓丽娜, 张雯文, 贺梦颖, 郭旭萌, 佘静亚. 血清tRF-Lys-CTT表达水平预测肺腺癌患者术后复发的临床意义[J/OL]. 中华肺部疾病杂志(电子版), 2025, 18(06): 936-941.
[12] 高瞻, 唐莎莎, 秦蘅, 王关嵩, 张雯. 慢性阻塞性肺疾病合并肺癌的临床特征及危险因素分析[J/OL]. 中华肺部疾病杂志(电子版), 2025, 18(05): 685-690.
[13] 姜宇丰, 张睿, 闵红巍. 全关节置换术后异位骨化的研究进展[J/OL]. 中华临床医师杂志(电子版), 2025, 19(07): 526-531.
[14] 姜彤彤, 戎萍, 马融, 付乾芳, 张亚同, 赵书艺, 刘晖, 马榕, 李悦, 李瑞本. 抽动障碍儿童呼吸道感染后的临床特征及抽动症状加重的危险因素分析[J/OL]. 中华临床医师杂志(电子版), 2025, 19(06): 426-432.
[15] 柴昌, 李定安, 姜进, 薛延华, 王衡. 前循环大血管闭塞性轻型卒中患者早期进展的危险因素及其补救性血管内治疗的临床疗效[J/OL]. 中华脑血管病杂志(电子版), 2025, 19(06): 503-510.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?